 |
|
Clinical Utility and Cost-effectiveness of an Air Suspension Bed in the Prevention of Pressure Ulcers
Kevin J. Inman, MSc;
William J. Sibbald, MD, FRCPC, FCCP;
Frank S. Rutledge, MD, FRCPC;
Barbara J. Clark, RN, BScN
JAMA. 1993;269(9):1139-1143.
Abstract
| |
Objective.
—To determine, in critically ill patients at risk, both the clinical utility and cost-effectiveness of using an air suspension bed in the prevention of pressure ulcers.
Design.
—Randomized, parallel group, controlled clinical trial with accompanying cost-effectiveness analysis.
Setting.
—30-bed multidisciplinary intensive care unit.
Patients.
—100 consecutive patients at risk for the development of pressure ulcers randomly assigned to receive treatment on either an air suspension bed or a standard intensive care unit bed. Patients considered at risk were those at least 17 years of age with an Acute Physiology and Chronic Health Evaluation II (APACHE II) score greater than 15 who had an expected intensive care unit stay of at least 3 days.
Main Outcome Measures.
—The development of pressure ulcers by site and severity and the costs associated with each of the two programs.
Results.
—The air suspension bed was associated with fewer patients developing single, multiple, or severe pressure ulcers. In patients at risk, the use of an air suspension bed in the prevention of pressure ulcers was a cost-effective therapy.
Conclusions.
—Despite intense nursing care, pressure ulcers are more prevalent in the critically ill patient population than in the general hospital population. Air suspension therapy provides a clinically effective means of preventing pressure ulcers in these patients. In patients at risk, air suspension therapy was a cost-effective means of managing pressure ulcers compared with the standard hospital bed.
(JAMA. 1993;269:1139-1143)
Author Affiliations
From the Richard Ivey Critical Care Trauma Centre and the Management and Evaluative Research Group, Victoria Hospital Corp, and the Program in Critical Care Medicine, Faculty of Medicine, University of Western Ontario, London.
Footnotes
Reprint requests to the Management and Evaluative Research Group, Victoria Hospital Corp, Room 482 NW, 375 South St, London, Ontario, Canada N6A 4G5 (Mr Inman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Extrinsic Risk Factors for Pressure Ulcers Early in the Hospital Stay: A Nested Case-Control Study
Baumgarten et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:408-413.
ABSTRACT
| FULL TEXT
Obesity Reduces the Risk of Pressure Ulcers in Elderly Hospitalized Patients
Compher et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007;62:1310-1312.
ABSTRACT
| FULL TEXT
Preventing pressure ulcers: a systematic review.
Reddy et al.
JAMA 2006;296:974-984.
ABSTRACT
| FULL TEXT
Pressure Ulcer Prevention and Management
Lyder
JAMA 2003;289:223-226.
FULL TEXT
Understanding Costs and Cost-Effectiveness in Critical Care . Report from the Second American Thoracic Society Workshop on Outcomes Research
Am. J. Respir. Crit. Care Med. 2002;165:540-550.
ABSTRACT
| FULL TEXT
Issues and Dilemmas in the Prevention and Treatment of Pressure Ulcers: A Review
Thomas
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001;56:M328-M340.
ABSTRACT
| FULL TEXT
The Ontario Health Care Evaluation Network and the Critical Care Research Network as Vehicles for Research Transfer
Sibbald and Kossuth
Med Decis Making 1998;18:9-16.
ABSTRACT
A Phase II Study to Evaluate Recombinant Platelet-Derived Growth Factor-BB in the Treatment of Stage 3 and 4 Pressure Ulcers
Mustoe et al.
Arch Surg 1994;129:213-219.
ABSTRACT
Pressure Ulcer Prevention With Low-Air-Loss Beds
Verdery
JAMA 1993;270:1197-1197.
ABSTRACT
|
